517 MYLAN
Pill imprint 517 MYLAN has been identified as Gemfibrozil 600 mg.
Gemfibrozil is used in the treatment of high cholesterol; hyperlipoproteinemia type v, elevated chylomicrons vldl; hyperlipoproteinemia; hyperlipoproteinemia type iib, elevated ldl vldl; hyperlipoproteinemia type iv, elevated vldl and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy.
Gemfibrozil 600 mg is not subject to the Controlled Substances Act.
See also related documents.
Gemfibrozil Images
- Imprint:
-
517
MYLAN - Strength:
- 600 mg
- Color:
- White
- Availability:
- Prescription only
- Drug Class:
- Fibric acid derivatives
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
More Gemfibrozil resources
- Gemfibrozil
- Gemfibrozil (Wolters Kluwer)
- gemfibrozil (Cerner Multum)
- gemfibrozil (Micromedex) - Includes Dosage Information
- Gemfibrozil (AHFS DI)
- Gemfibrozil (FDA)
- Gemfibrozil (Wolters Kluwer)


